Ansøgningsnr. og dato | 11192240.7 (espacenet) (Federated) (European Patent Register), 20061205 | Patent/reg.nr. og dato | DK/EP 2481753, 20180418 | Tilgængelighedsdato | 20120801 | Prioritetsnr. og dato | US 749953 P, 20051213, US 801948 P, 20060519 | EP publ. nr. og dato |
EP 2481753 20120801 | Løbedag | | Ansøger/indehaver | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | Ansøgers ref. nr. | P81203112DK01E | Opfinder | NG, Kingman, 10745 Putnam Place
Carmel, Indiana 46032, US, Allan, Barrett, Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285, US, Chow, Chi-kin, Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285, US, Huang, Lihua, Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285, US, Liu, Ling, Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285, US, Lu, Jirong, Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285, US, Tetreault, Jonathan Wendell, Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285, US, Werner, Andrew Gordon, Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285, US | Fuldmægtig | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Interessent på tilknyttet sag | | IPC-Klasse | A61K 39/395 (2006.01) , C07K 16/24 (2006.01) | Titel/benævnelse | Anti-IL-17-antistoffer | Internationalt ansøgningsnr. | | Internationalt publ. nr. | | Relateret sag (certifikat) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|